Latest news with #JoshJennings
Yahoo
2 days ago
- Business
- Yahoo
TD Cowen Maintains a Buy on Stryker Corporation (SYK) With a $435 PT
Stryker Corporation (NYSE:SYK) is one of the top low volatility healthcare stocks to buy now. In a report released on July 20, Josh Jennings from TD Cowen maintained a Buy rating on Stryker Corporation (NYSE:SYK) with a price target of $435.00. A medical team wearing surgical masks and gloves carrying out a hip or knee joint replacement surgery with the help of surgical navigation systems. The analyst based the optimistic rating on the company's strong performance in recent quarters and the anticipation of continued momentum. Jennings stated that Stryker Corporation (NYSE:SYK) has consistently experienced robust growth, reporting a notable 10% organic growth in Q1, which translates to around 11.1% when adjusted for a selling day headwind. He further stated that Stryker Corporation (NYSE:SYK) is positioned against one of its easier comparisons from 2024 despite an expected slowdown in growth to 8.8% for Q2. According to Jennings, the company has historically achieved double-digit growth even in the backdrop of challenging benchmarks, suggesting that the present market estimates are well-founded. Stryker Corporation (NYSE:SYK) is a medical technology company that offers products and services in Neurotechnology, Medical and Surgical, and Orthopedics and Spine. It operates through the MedSurg and Neurotechnology and the Orthopedics and Spine segments. The company's medical devices and products include surgical navigation systems, surgical equipment, emergency medical equipment, endoscopic and communications systems, neurosurgical and neurovascular devices, Mako Robotic-Arm Assisted technology, and several other products. Stryker Corporation (NYSE:SYK) holds around 13,000 global patents to shield its products from replication. While we acknowledge the potential of SYK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Otago Daily Times
17-07-2025
- Sport
- Otago Daily Times
Bulls serve up fresh approach for playoff
Linwood are taking a novel build-up into the preliminary finals of the Metro premier competition on Saturday. Instead of arduous training sessions at their Linfield Park home ground, the squad has recently opted for short Thursday night sessions on the grass, before going out for a team dinner. They face High School Old Boys at Bob Deans Field on Saturday, with the winner advancing to next week's grand final. Head coach Brendon Nolan said the focus in recent weeks had been on building team connections. 'I'm real keen for the guys just to bond and recognise the moments we're creating at the moment,' he said. 'You can skip through them pretty quickly and then it's a bit late to reflect on. But if you're living in the moment and enjoying it, it's awesome.' The proof is in the pudding – Linwood toppled Sydenham 35-25 on Saturday to reach the preliminary finals stage of the competition for the third consecutive season. Despite being outscored four tries to three, they relied on the boot of first-five Josh Jennings, who slotted six penalties to put his team out of reach. 'Everyone's nailing their role, which is good for us at the moment,' Nolan said. 'The management, the groundsman, all the backroom staff, and the boys are just knuckling down. 'It's a good spot to be in.' In the other preliminary final, top seeds Marist Albion will take on surprise package Lincoln University, who upset University of Canterbury 25-19 on Saturday. Lincoln defended stoutly for the last two minutes before debutant Angus Reeves secured a vital turnover, which allowed his team to kick the ball out and clinch the victory. It is the first time Lincoln has reached this stage of the competition since 2022. Captain Zach Parkin said his men had improved as the season progressed, especially after going down 52-17 to University in round 3. 'On Saturday we lifted again and our defence closed it out,' he said. 'Everyone was out on their feet, absolutely buggered. It was a pretty unreal effort to finish.' Parkin said Marist will be a tough opponent, with Lincoln having lost 33-26 when the teams met earlier in the season. In the plate competition, New Brighton halfback Tyson Belworthy redeemed himself in their semi-final. After missing a potentially match-winning penalty in last week's premier semi-final loss to Lincoln, Belworthy slotted a conversion in the last seconds to seal a 22-21 win over Sumner. In the other plate semi-final, Belfast beat Burnside 55-19. New Brighton and Belfast will now meet in the final at Rawhiti Domain. Metro premier preliminary finals (2.45pm Sat) • HSOB v Linwood, Bob Deans Field; • Marist Albion v Lincoln University, Edgar MacIntosh Park • New Brighton v Belfast, Rawhiti Domain
Otago Daily Times
17-07-2025
- Sport
- Otago Daily Times
Bulls serve up fresh approach for Chch Metro playoff
Linwood are taking a novel build-up into the preliminary finals of the Metro premier competition on Saturday. Instead of arduous training sessions at their Linfield Park home ground, the squad has recently opted for short Thursday night sessions on the grass, before going out for a team dinner. They face High School Old Boys at Bob Deans Field on Saturday, with the winner advancing to next week's grand final. Head coach Brendon Nolan said the focus in recent weeks had been on building team connections. 'I'm real keen for the guys just to bond and recognise the moments we're creating at the moment,' he said. 'You can skip through them pretty quickly and then it's a bit late to reflect on. But if you're living in the moment and enjoying it, it's awesome.' The proof is in the pudding – Linwood toppled Sydenham 35-25 on Saturday to reach the preliminary finals stage of the competition for the third consecutive season. Despite being outscored four tries to three, they relied on the boot of first-five Josh Jennings, who slotted six penalties to put his team out of reach. 'Everyone's nailing their role, which is good for us at the moment,' Nolan said. 'The management, the groundsman, all the backroom staff, and the boys are just knuckling down. 'It's a good spot to be in.' In the other preliminary final, top seeds Marist Albion will take on surprise package Lincoln University, who upset University of Canterbury 25-19 on Saturday. Lincoln defended stoutly for the last two minutes before debutant Angus Reeves secured a vital turnover, which allowed his team to kick the ball out and clinch the victory. It is the first time Lincoln has reached this stage of the competition since 2022. Captain Zach Parkin said his men had improved as the season progressed, especially after going down 52-17 to University in round 3. 'On Saturday we lifted again and our defence closed it out,' he said. 'Everyone was out on their feet, absolutely buggered. It was a pretty unreal effort to finish.' Parkin said Marist will be a tough opponent, with Lincoln having lost 33-26 when the teams met earlier in the season. In the plate competition, New Brighton halfback Tyson Belworthy redeemed himself in their semi-final. After missing a potentially match-winning penalty in last week's premier semi-final loss to Lincoln, Belworthy slotted a conversion in the last seconds to seal a 22-21 win over Sumner. In the other plate semi-final, Belfast beat Burnside 55-19. New Brighton and Belfast will now meet in the final at Rawhiti Domain.
Business Insider
07-06-2025
- Business
- Business Insider
TD Cowen Reaffirms Their Buy Rating on Humacyte (HUMA)
TD Cowen analyst Josh Jennings maintained a Buy rating on Humacyte (HUMA – Research Report) today. The company's shares opened today at $2.66. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Jennings is a 4-star analyst with an average return of 4.6% and a 52.11% success rate. Jennings covers the Healthcare sector, focusing on stocks such as Abbott Laboratories, Medtronic, and Establishment Labs Holdings. Humacyte has an analyst consensus of Strong Buy, with a price target consensus of $11.20. Based on Humacyte's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $517 thousand and a net profit of $39.14 million. In comparison, last year the company had a GAAP net loss of $31.9 million Based on the recent corporate insider activity of 26 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HUMA in relation to earlier this year. Most recently, in April 2025, William John Scheessele, the CCO of HUMA bought 6,493.00 shares for a total of $9,999.22.
Business Insider
06-06-2025
- Business
- Business Insider
PROCEPT BioRobotics (PRCT) Gets a Buy from TD Cowen
In a report released yesterday, Josh Jennings from TD Cowen reiterated a Buy rating on PROCEPT BioRobotics (PRCT – Research Report). The company's shares closed yesterday at $65.05. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Jennings covers the Healthcare sector, focusing on stocks such as Abbott Laboratories, Medtronic, and Establishment Labs Holdings. According to TipRanks, Jennings has an average return of 4.6% and a 52.11% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for PROCEPT BioRobotics with a $80.20 average price target. PRCT market cap is currently $3.32B and has a P/E ratio of -36.24. Based on the recent corporate insider activity of 43 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PRCT in relation to earlier this year. Most recently, in March 2025, Reza Zadno, the President & CEO of PRCT sold 5,475.00 shares for a total of $312,403.50.
